Contributing sites

Madagascar, Antananarivo

Institut Pasteur de Madagascar

Since 2024-2025

The Institut Pasteur de Madagascar (IPM) is a private scientific institution in Madagascar, operating as a non-profit organization and recognized as being of public utility. It operates under the high patronage of the Government of the Republic of Madagascar and is governed by the 1961 agreement that links the Institut Pasteur in Paris with the Government of the Republic of Madagascar.

Website
https://www.pasteur.mg/ (in French)

Contacts
Vincent Lacoste, Main Investigator

Hospitals
• Centre Hospitalier de Soavinandriana
• Centre Hospitalier Universitaire Mère et Enfant Ambohimiandra (CHUMEA)
• Centre Hospitalier Universitaire Mère et Enfant Tsaralalana (CHUMET)

Nigeria, Abuja

Nigeria Centre for Disease Control and Prevention

Since 2024-2025

The Nigeria Centre for Disease Control and Prevention (NCDC) is the national public health institute with the mandate to lead the preparedness, detection and response to infectious disease outbreaks and public health emergencies. The first formal step to establish the NCDC took place in 2011 when some departments in the Ministry of Health, including the Epidemiology Division, the Avian Influenza Project and its laboratories; and the Nigeria Field Epidemiology and Laboratory Training Programme (NFELTP) were moved to form the nucleus of the agency. The Bill for an Act to establish NCDC was signed into law in November 2018, by President Muhammadu Buhari.

Website
https://ncdc.gov.ng/ncdc.gov.ng/ (in English)

Contacts
Sikiru Olanrewaju Badaru, Main Investigator

Hospitals
• Asokoro District Hospital, Abuja
• Aminu Kano Teaching Hospital, Kano
• Bwari General Hospital, Bwari – Abuja
• Ikot-Ekpene General Hospital, Ikot-Ekpene – Akwa-Ibom
• Lagos State University Teaching Hospital, Ikeja – Lagos
• Lagos University Teaching Hospital – Idi-Araba, Lagos
• Maitama District Hospital, Maitama-Abuja
• Nnamdi Azikiwe University Teaching Hospital, Nnewi-Anambra
• Nyanya General Hospital, Nyanya-Abuja
• Defense Headquarters Medical Centre, Mogadishu-Abuja
• University College Hospital, Ibadan-Oyo
• University of Maiduguri Teaching Hospital, Maiduguri-Bornu

Senegal, Dakar

Institut Pasteur of Dakar (IPD)

Since 2021-2022

The Institut Pasteur of Dakar Foundation (IPD) is a non-profit association of public utility, concerned with promoting public health and well-being in West Africa. Since its founding in 1896 by one of Louis PASTEUR’s disciples, Émile Marchoux, the IPD has been at the forefront of the fight against infectious diseases. Since 2009, the Institut Pasteur de Dakar has been a Senegalese foundation, jointly managed by the government of Senegal and the Institut Pasteur (Paris).

Website
https://www.pasteur.sn/en (in english)

Contact
Ndongo DIA, Main Investigator

Hospitals
• Hôpital Albert Royer Dakar, CHU FANN
• Hôpital Général Idrissa Pouye de Grand Yoff
• Hôpital d’enfants de Diamniadio (HED)

South Africa, Johannesburg

Respiratory and Meningeal Pathogens Research Unit

Since 2016-2017

RMPRU is a research Unit focused on the epidemiology, transmission, prevention and diagnosis of vaccine preventable diseases. RMPRU forms part of and is administered by the Wits Health Consortium, a wholly owned subsidiary of the University of the Witwatersrand.

RMPRU was established in 1997, with an original research mandate to investigate pneumococcal diseases at the molecular, epidemiological, clinical and pharmacological levels. Over time, the Unit has evolved to include investigating the clinical and molecular epidemiology of other bacteria and respiratory viruses that are associated with pneumonia and meningitis. Also, the Unit has established itself to be a premier clinical trial facility for vaccine and training platforms for post-graduate students.

The Unit has undertaken pivotal studies on pneumococcal conjugate vaccine, which have helped inform the utilisation of these vaccines in low-to-middle income countries. Also, the pneumococcal vaccine studies have helped inform the interaction of pneumococcus in relation to respiratory viruses and tuberculosis associated acute community acquired pneumonia. More recently, the Unit has further evolved to focus specifically on the epidemiology and prevention of infections during the neonatal period, including programs aimed at vaccinating pregnant women to confer passive immunity and protect infants during their first few months of life. These include studies on the influenza vaccines, GBS conjugate vaccine, pertussis vaccine and RSV vaccines.

Contacts
Vicky Baillie, Main Investigator

Hospital
• Chris Hani Baragwanath Academic Hospital

South Africa, Mthatha

Nelson Mandela Academic Clinical Research Unit

Since 2024-2025

The Nelson Mandela Academic Clinical Research Unit (NeMACRU) is a research entity of the Nelson Mandela Academic Hospital established by the hospital in association with the Walter Sisulu University, Faculty of Health Sciences. NeMACRU is located in one of the poorest districts (OR Tambo District Municipality) of the Eastern Cape Province. The existence of this site will not only promote excellent research output in the area but will support local health facilities with health education on vaccines and HIV Prevention.

Website

Contacts
Prof. T. Apalata, Main Investigator

Hospitals
• Nelson Mandela Academic Clinical Research Unit
• Mthatha Regional Hospital
• Cecillia Makhiwane
• Frere
• Dora Nginza

Tunisia, Tunis

Institut Pasteur de Tunis

From 2016-2017 to 2027-2018

The Pasteur Institute of Tunis, located in Tunis, Tunisia is one of the main research centers of the International Network of Institutes Pasteur.
Founded in 1893 by Adrien Loir, it was initially made to be a rabies vaccine center. Located in rue des Tanneurs in Tunis, and now the laboratory currently does research on winemaking and diseases of the vine. A large part of the institutions prestige can be contributed to Charles Nicolle, a bacteriologist and the director between 1902 and 1936, who discovered the cause of typhus ( Rickettsia spp.) during this period of time.

Website
http://www.pasteur.tn/

Contact
Dr Ben Salah, Main Investigator & Project Director

Argentina, Buenos Aires

The National Reference Laboratory for Influenza and other respiratory viruses

From 2017-2018 to 2018-2019

Since 1996 the National Reference Laboratory/WHO National Influenza Centre (NIC) of Argentina serves as a central repository for acute respiratory illness surveillance data.

The central hospital of the study is a health institution, where activities of prevention, treatment, diagnosis and rehabilitation are conducted, as well as teaching and research activities.

The identification of influenza and other respiratory viruses is conducted at the Respiratory Virus Laboratory, Virology Department, including the influenza subtyping, determination of the influenza B lineages and influenza A and B genomic characterization according to the protocol of a real time platform validated by the US Center for Disease Control and Prevention (CDC).

Contact
• Pr Elsa BAUMEISTER, Main Investigator & Project Director
• Pr Graciela CABRAL, Co-Investigator & Project Coordinator

Hospital
National Hospital “Prof Alejandro Posadas” (Villa Sarmiento City, Buenos Aires Province)

Brazil, Curitiba

Hospital Pequeno Principe

Since 2018-2019

Pequeno Principe Hospital is a philanthropic institution, being a reference in pediatrics in the country.

It has performed influenza hospital-based surveillance since 2010, being a sentinel reference to cases of severe acute respiratory infection (SARI) for pediatric patients from Curitiba and other metropolitan region municipalities.

The hospital has a Department of Epidemiology and Infection Control that performs this surveillance. This department has participated in the GIHSN project – 2018- 2019 season and 2019-2020.

Website
http://pequenoprincipe.org.br/ (in english and portuguese)

Contact
• Pr Sonia M. RABONI, Main Investigator
• Heloisa I. G. GIAMBERARDINO, Co-Investigator

Hospital
Hospital Pequeno Principe (Curitiba City, Paraná State)

Brazil, Rio de Janeiro

Fiocruz/Fondation Mérieux

From 2013-2014 to 2015-2016

Contact

Hospital

Canada, Halifax

Canadian Center for Vaccinology

Since 2017-2018

The Canadian Center for Vaccinology (CCfV) is a multidisciplinary vaccinology research centre of Dalhousie University developed with funding from the Canada Foundation for Innovation, which brings together investigators from adult and pediatric infectious diseases, internal medicine, geriatrics, health law and bioethics, public health, nursing, pharmacy, epidemiology, health outcomes and health economics. CCfV is the lead institution and coordinating center for the Canadian Immunization Research Network. The SOS Network is coordinated by the Canadian Center for Vaccinology in Halifax, Nova Scotia.

Website
https://centerforvaccinology.ca/ (in english)

Contact
• Dr Shelly A. McNEIL, Main Investigator
• Dr Melissa K. ANDREW, Co-Investigator

Hospitals
• Dartmouth General Hospital
• QEII Health Sciences Centre, Halifax NS

Colombia, Cartagena

Laboratorio UNIMOL, Universidad de Cartagena

From 2018 to 2019 and since 2024-2025

Website
https://unicartagena.edu.co

Contacts
Doris Gómez Camargo, Main Investigator

Hospitals
• E.S.E. Hospital Universitario del Caribe
• Fundación Hospital Infantil Napoleón Franco Pareja

Colombia, Medellin

Laboratorio de Salud Pública de Antioquia

Since 2024-2025

Website

Contacts
Idabely Betancur Ortiz, Main Investigator

Hospitals
• Hospital San Vicente Foundation
• Hospital Yarumal
• Hospital Pablo Tobón Uribe
• Hospital Manuel Uribe Ángel
• Clinica Somer de Rionegro
• Hospital de Caucasia
• Hospital de Santa Fe de Antioquia
• Hospital San Rafael de Itagüí
• Hospital de Puerto Berrío
• Hospital de Andes

Guatemala, Coatepeque/Chiquirines

Fundación para la Salud Integral de los Guatemaltecos

Since 2024-2025

The Fundación para la Salud Integral de los Guatemaltecos, Funsalud, is a private non-profit organization aimed at addressing the health and development challenges of communities in the Trifinio Sur region of Guatemala.

Website
Facebook page only: https://www.facebook.com/people/Fundaci%C3%B3n-para-la-Salud-Integral-de-los-Guatemaltecos-Funsalud/100068592684218/

Contacts
Daniel Olson, Main Investigator

Hospitals
• Hospital Nacional De Coatepeque “Juan José Ortega”
• Hospital Nacional de Chimaltenango

Mexico, Mexico City

Instituto Nacional de Enfermedades Respiratorias

Since 2024-2025

The Instituto Nacional de Enfermedades Respiratorias is a decentralized entity of the Federal Public Administration, with its own legal personality and assets, grouped under the Health Sector. Its primary objective in the field of respiratory diseases is scientific research, the training and education of qualified human resources, and the provision of highly specialized medical care services, with jurisdiction across the entire national territory.

Website
https://www.gob.mx/salud%7Ciner/en (in English)

Contacts
Joel Armando Vazquez-Perez, Main Investigator

Hospitals
• Instituto Nacional de Enfermedades Respiratorias
• Instituto Nacional de Enfermedades Respiratorias
• Instituto Nacional de Cancerología

Mexico, Mexico City

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

From 2015-2016 to 2020-2021

The Ministry of Health Coordination Center of the National Institutes of Health and High Speciality Hospital (CCINSHAE)’s mission is to promote the highest level of scientific knowledge and to develop, maintain, and renew scientific human and physical resources that will ensure the Nation’s capability to prevent disease, enhance health and reduce illness and disability.

The Mexico National Institutes of Health and High Specialty Hospitals Surveillance Network integrate 12 National Health Institutions and Hospitals to ensure a wide geographic representation of the north, central and south areas of the country. Its purpose is the timely identification and estimation of the incidence of severe illness (hospitalization) and the description of the clinical characteristics caused by influenza and other respiratory viruses, as well as new and emerging infectious treats to ultimately protect and improve the health of the individual and the allocation of economic resources.

Website
https://www.incmnsz.mx/opencms/ (in spanish)

Contact
• Dr Guillermo M. RUIZ-PALACIOS, Main Investigator
• María de LOURDES GUERRERO, Co-Investigator

Hospitals
• Instituto Nacional de Ciencias médicas y Nutrición Salvador Zubirán (Mexico City)
• Instituto Nacional de Enfermedades Respiratorias (Mexico City)
• Instituto Nacional de pediatría (Mexico City)
• Hospital Infantil de México (Mexico City)
• Hospital General Dr. Manuel Gea González (Mexico City)
• Hospital Central Dr. Ignacio Morones Prieto (San Luis Potosí City, San Luis Potosí State)

Peru, Lima

Tropical Medicine Institute Daniel A. Carrion, San Marcos University, Lima – Peru and Centro de Investigaciones Tecnológicas, Biomédica y Medioambientales

Since 2016-2017

The Tropical Medicine Institute Daniel Carrion´s mision is to promote a highest level of scientific knolewdge in Tropical Infectious Diseases to contribute in the health care of the peruvian population. This Tropical Institute (IMT DAC in Spanish)works closely with the CITBM under a collaborative agreementincluding associate business and international research activities.

CITBM is the first Center of Excellence in Peru dedicated to the integration of science, development and technological innovation. CITBM is collaborating in multiple national and multinational biomedical, technology and innovation projects, including the development of rapid diagnostic tests and vaccines for infectious tropical diseases as malaria, leptospirosis, leishmaniasis and meningeal tuberculosis. Additionally, it leads the international consortium MDRTBNet (aERANet Lac initiative), with reference institutes of tuberculosis in Germany, Spain, France, Brazil and Italy.

Website
http://citbm.unmsm.edu.pe/ (in spanish)

Contact
Dr Víctor A. LAGUNA TORRES, Main Investigator

Hospitals
• Hospital Santa Rosa Piura. Ministry of Health, Peru
• Carlos Alberto Seguin HNCASE, Social Security System Arequipa (EsSalud)
• Clinica Internacional, Two sites San Borja and Lima, Lima Peru
• Hospital Nacional Daniel Alcides Carrion

United States of America, New York City

Icahn School of Medicine at Mount Sinai

Since 2021-2022

The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, which includes eight hospital campuses, and has more than 5,000 faculty and nearly 2,000 students, residents and fellows. Our unwavering pursuit of intellectual exchange, breakthrough research, and multidisciplinary teamwork propels us ever forward in biomedical discoveries and advances. We pursue ideas that often challenge conventional wisdom to revolutionize the practice of medicine and produce dramatically better outcomes for patients. We make big, bold bets by investing in radical free thinkers and technology at the cutting edge.

Website
https://icahn.mssm.edu/ (in english)

Contact
Dr. Viviana SIMON, Main Investigator
Dr. Harm VAN BAKEL, Co-Investigator
Dr. Mia Emilia SORDILLO, Co-Investigator

Hospital
• Mount Sinai Morningside
• Mount Sinai West
• Mount Sinai Brooklyn
• Mount Sinai Queens
• Mount Sinai Beth Israel
• The Mount Sinai Hospital

China, Hong Kong

The University of Hong Kong, Department of Microbiology

Since 2024-2025

Having a long-standing tradition of adopting a “Bench to Bedside” approach, The Department of Microbiology at The University of Hong Kong works closely with its affiliated Department of Microbiology at Queen Mary Hospital and Department of Clinical Microbiology & Infection Control at HKU-Shenzhen Hospital to provide excellent health care service in three major area.

Website
https://hkumicro.hku.hk/ (in English)

Contacts
Kelvin To, Main Investigator

Hospitals
• Queen Mary Hospital

China, Hong Kong

The Chinese University of Hong Kong

Since 2024-2025

Founded in 1963, The Chinese University of Hong Kong (CUHK) is a forward-looking comprehensive research university with a global vision and a mission to combine tradition with modernity, and to bring together China and the West. CUHK teachers and students hail from all around the world. CUHK graduates are connected worldwide through an extensive alumni network.

Website
https://www.cuhk.edu.hk/english/index.html (in English)

Contacts
Lai Koon Chi Christopher, Main Investigator

Hospitals
• Prince of Wales Hospital

China, Shanghai

Fudan University

From 2016-2017 to 2021-2022

The study team is composed by the School of Public Health, Fudan University (SPH), Soochow University Affiliated Children’s Hospital (SCH) and Suzhou Center for Disease Control and Prevention (CDC).

All three institutions are well coordinated since foundation by US CDC in March 2011.
Fudan University is a comprehensive research university in China. As one of the first participants in the 211 and 985 projects. Fudan has 28 schools and 11 affiliated hospitals.

Since Mar 2011, founded by US CDC, the influenza surveillance system was established in Soochow University Affiliated Children’s Hospital (SCH). The surveillance includes influenza-like illness (ILI) and severe acute respiratory infection (SARI) patients.

SCH is a comprehensive tertiary hospital for children, one of the national influenza monitoring network hospitals, integrated with medical treatment, teaching, research and preventive health care.

Website
http://shmc.fudan.edu.cn/eng (in english and chinese)

Contact
Dr Tao ZHANG, Main Investigator & Coordinator

Hospital
Children’s Hospital of Soochow University (Soochow City, Jiangsu Province)

India, Srinagar

Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Department of Internal and Pulmonary Medicine

From 2015-2016 to 2022-2023

The SKIMS is engaged to provide high quality patient care, academic courses and need-based biomedical research to provide better patient care.

The institute has been one of the sites of the CDC,USA sponsored Multisite Surveillance for Influenza across India that has documented the patterns of influenza circulation in India.

Website
http://skimsmc.edu.in/ (in english)

Contact
Dr Parvaiz KOUL, Main Investigator

Hospital
Sher-i-Kashmir Institute of Medical Sciences SKIMS (Srinagar City, Jammu & Cashmir Territory)

Kazakhstan, Almaty

Scientific Practical Center of Sanitary and Epidemiological Expertise and Monitoring” filial branch of the National Centre of Public Health, Ministry of Health Republic of Kazakhstan

From 2016 to 2017

Republican state enterprise on the right of economic management «National Centre of Expertise» of the Committee of Sanitary and Epidemiological Control of the Ministry of Health of the Republic of Kazakhstan carries out activities in the field of sanitary and epidemiological welfare of the population. NEC is a system with a wide branch network that covers the whole territory of the Republic of Kazakhstan. The center consists of a central office and 21 branches of which:
• 17 regions and 2 cities in Almaty and Astana;
• 176 district offices of branches;
• 2 centers of disinfection in the Almaty city and Shymkent.

Website
http://shmc.fudan.edu.cn/eng

Contact
Ainagul Kuatbaeva, Main Investigator & Project Director

Nepal, Patan

Patan Academy of Health Sciences

From 2019-2020 to 2022-2023

Patan Academy of Health Sciences (PAHS) is a non-profit, public, health science university established with an act of parliament in 2008. The central rationale for the establishment of PAHS was to contribute to the reduction of disparity in the health status among rural, urban, and disadvantaged populations in Nepal.

The site is a collaborating Oxford vaccine research group and implementing influenza surveillance project supported by US Centers for Disease Control and Prevention since 2009.

Until 2009, influenza-related surveillance work were patchy and has not had systematic effort. To systematize and strengthen influenza surveillance activities, PAHS participated in CDC influenza call and received a grant in 2009.

After the establishment of Nepal National Influenza Center in 2010, national health system started testing influenza sample within the country. Since then, Patan Academy started Influenza surveillance as one of the sentinel sites in Nepal under NIC.

Since 2011 Patan hospital sentinel sites have been collecting ILI epidemiological data and sample regularly on weekly basis.

Website
https://www.pahs.edu.np/ (in english)

Contact
Kedar P. BARAL, Main Investigator

Hospital
• Patan Hospital

Czech Republic, Prague

National Institute of Public Health

From 2014-2015 to 2017-2018

The National Institute of Public Health (NIPH) is a health care establishment for basic preventive disciplines – hygiene, epidemiology, microbiology and occupational medicine. Its main tasks are health promotion and protection, disease prevention and follow-up of environmental impact on the health status of the population.

Website
https://www.inserm.fr/

Contact
• Dr Jan Kyncl, Main Investigator & Project Director

France, Lyon

Edouard Herriot Hospital, Department of Hygiene, Epidemiology and Prevention

From 2017-2018 to 2019-2020

Surveillance of nosocomial influenza was set-up in Edouard Herriot hospital in 2004 to estimate the risk of hospital acquired-ILI for hospitalized patients in short-stay units, and to identify determinants associated with nosocomial Influenza infection. Determinants from the community (influenza incidence, vaccine coverage, etc.) and from the hospital (underlying diseases, two-bed rooms, vaccine coverage among HCW, etc.) are explored to describe and initiate preventive measures to avoid hospital outbreak of influenza.

Since 2012 the hospital is involved into the FluVac study. This is a case-control prospective study coordinated by the REIVAC (Réseau national d’investigation clinique en vaccinologie). The main objective of this study is to assess the effectiveness of influenza vaccine in hospitalized patients with laboratory-confirmed influenza.

Contact
Pr Philippe VANHEMS, Main Investigator

Hospital
Edouard Herriot Hospital (Lyon City)

France, Paris

I-REIVAC network – Inserm

From 2019-2020 to 2021-2022

5 universitary hospitals, all members of I-REIVAC network, are involved in the project in 2019-2020.

The I-REIVAC coordination team manage the monitoring of data in connecting with the local teams of each site to correct the errors, incoherencies or missing values within the database.

Website
https://www.inserm.fr/ (in french and english)

Contact
• Pr Odile LAUNAY, Main Investigator
• Dr Can L. LUONG, Co-Investigator
• Zineb LESIEUR, Co-Investigator

Hospital
• Hôpital Cochin (Paris City)
• Hôpital Bichat (Paris City)
• Hospices Civils de Lyon (Lyon City)
• Centre Hospitalier Universitaire de Montpellier (Montpellier City)
• Centre Hospitalier Universitaire de Rennes (Rennes City)

Poland, Warsaw

National Institute of Tuberculosis and Lung Diseases

Since 2023 – 2024

National Institute of Tuberculosis and Lung Diseases in Warsaw is a leading Polish research and clinical centre. It has long-term experience in the research and implementation of new technologies and therapies in the domain of lung diseases with main focus on COPD, SDB, interstitial lung diseases, and lung cancer. Due to its key clinical and scientific position in respiratory medicine in Poland, the institute serves as the national reference pulmonary clinical centre. The institute established, e.g., as first in Poland, the long-term oxygen therapy centre in 1986 and the non-invasive ventilation centre in 1996 to treat chronic respiratory failure. In 1988, the sleep laboratory was developed as a first in the country. These facilities have served for a long time as a main teaching site for students and physicians interested in chronic respiratory failure and OSA.

Website
https://www.igichp.edu.pl/ (in polish)

Contact
Joanna Chorostowska-Wynimko, Main Investigator

Hospitals
• National Institute of Tuberculosis and Lung Diseases
• University Clinical Hospital – Central Veteran Hospita
• Saint Family Specialized Hospital
• Pediatric Teaching Clinical Hospital

Romania, Bucharest

The National Institute for Infectious Diseases “Prof. Dr. Matei Bals”

Since 2016-2017

The National Institute for Infectious Diseases “Prof. Dr. Matei Bals” is the excellence center in Romania for prevention, management and research in area of infectious diseases. As a research center, the hospital has extensive experience in conducting clinical trials in the field of infectious diseases having a dedicated and accredited (FDA) clinical trials center. Vaccine trials were routinely conducted in National Institute of Infectious Diseases “Prof. Dr. Matei Bals” Bucharest (flu, pneumococcal)Severe influenza cases, both in adult and pediatric population are managed in the Institute.

The Institute is also part in the national influenza surveillance system (Romania has a national sentinel type surveillance system for influenza).A dedicated hospital epidemiology unit contributes to the national influenza surveillance program.

Contacts
Anca DRAGANESCU, Main Investigator

Hospital
National Institute for Infectious Diseases “Prof. Dr. Matei Bals” (Bucharest City, Bucharest Municipality)

Russia, Moscow

FSBI National Center of Epidemiology and Microbiology by N.F.Gamaleya

Since 2012-2013

D.I. Ivanovsky Institute of Virology is one of the first-rate research organizations in the field of ecology, epidemiology, molecular biology, and molecular virology. Its mission is fundamental researching of virology, development and improvement of diagnostic methods and assessment of new antivirals against highly infectious and social diseases. Institute has been involved in influenza surveillance since 1959 both in Russia (USSR) and WHO. Since 2014 Institute had became a part of FSBI “N.F. Gamaleya FRCEM”.

Website
https://gamaleya.org/en/ (in english and russian)

Contact
Elena BURTSEVA, Main Investigator

Hospital
Clinical Hospital for Infectious Diseases n°1 (Moscow City, Central Federal District)

Russia, St-Petersburg

Smorodintsev Research Institute of Influenza

Since 2012-2013

RII is a leading institution in the field of influenza and ARI surveillance in Russia.

RII incorporates Federal Influenza and ARI Centre and WHO National Influenza Centre, successfully operating both on the national and global levels as an integral part of WHO global influenza surveillance and response system.

Website
https://www.influenza.spb.ru/en/ (in english and russian)

Contact
Daria Danilenko, Main Investigator

Hospitals
• Infectious Clinical City Hospital #1 (Novosibirsk) (code #9)
• Children’s Clinical City Hospital #3 (Novosibirsk) (code #8)
• Children’s Clinical City Hospital #6 (Novosibirsk) (code #7)
• Children’s Multidisciplinary Hospital # 4 named after Saint Olga (St.- Petersburg) (code # 3)
• Children’s Infectious Multidisciplinary Hospital # 5 named after N.F. Filatov (St.-Petersburg) (code # 2)
• Clinical Infectious Diseases Hospital named after S.P. Botkin, (St.- Petersburg) (code #1)

Serbia, Novi Sad

Institute of Public Health of Vojvodina

From 2017-2018 to 2019-2020

The Institute of public health (IPH) of Vojvodina have significant scientific and practical experience in the field of influenza and immunization that has been acquired in numerous studies. The IPH of Vojvodina is the leading state Institution for the communicable diseases surveillance (including influenza) that are envisaged for compulsory reporting in Vojvodina.

The World Health Organization (WHO) as the National Influenza Centre (NIC) has recognized the IPH of Vojvodina, Centre of virology, since 1953. NIC is part of the WHO Global Influenza Surveillance Network, with the principal task of continuous virologic surveillance of influenza virus activity in population of Vojvodina.

Website
http://www.izjzv.org.rs/ (in serbian and english)

Contact
• Dr Snežana MEDIC, Main Investigator & Project Coordinator
• Dr Mioljub RISTIC, Co-Investigator & Province Coordinator

Hospitals
• Institute of Pulmonary Diseases of Vojvodina (Sremska Kamenica City, Autonomous Province of Vojvodina)
• Clinical Center of Vojvodina (Novi Sad City, Autonomous Province of Vojvodina)
• Institute for Health Care of Children and Youth of Vojvodina (Novi Sad City, Autonomous Province of Vojvodina)

Spain, Valencia

FISABIO

Since 2012-2013

The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, is a non-profit scientific and healthcare entity, whose primary purpose is to encourage, to promote and to develop scientific and technical health and biomedical research in Valencia Region.

FISABIO integrates and manages the Health Research Map of the Centre for Public Health Research, Dr. Peset University Hospital Foundation, Alicante University General Hospital Foundation, Elche University General Hospital Foundation, and the Mediterranean Ophthalmological Foundation. In addition, FISABIO assumes the scientific activity of other 18 Health Departments.

Website
http://fisabio.san.gva.es/ (in english, spanish and catalan)

Contact
Alejandro Orrico Sanchez, Main Investigator

Hospitals
• Hospital General de Castellón (Castellón)
• Hospital Universitario y Politécnico La Fe (Valencia)
• Hospital General Universitario de Valencia (Valencia)
• Hospital Universitario Doctor Peset (Valencia)
• Hospital Marina Baixa (Alicante)

Lebanon, Beirut

American University of Beirut Medical Center

Since 2018-2019

Infectious diseases remain among the leading causes of morbidity and mortality in the Middle East, with diseases such as pneumonia, gastroenteritis, malaria, and tuberculosis presenting a major burden in our region.

The Center for Infectious Diseases Research (CIDR) at the American University of Beirut Medical Center (AUBMC) promotes research in basic, translational, and clinical aspects of infectious diseases.

The aim of the CIDR laboratory is to function as a national and regional reference laboratory with emphasis on the diagnosis of endemic and epidemic infectious diseases relevant to our region.

Website
https://www.aubmc.org.lb/pages/home.aspx (in english)

Contact
Dr Ghassan DBAIBO, Main Investigator

Hospitals
• Beqaa Hospital (Taalabaya City, Bekaa region, Zahleh district)
• Rafic Hariri University Hospital (Beirut City)
• New Mazloum Hospital (Tripoli City, North Lebanon region, Tripoli district)
• Keserwan Medical Center KMC (Jounieh City, Mount Lebanon region, Keserwan district)
• American University of Beirut Medical Center (Beirut City)
• Hammoud Hospital University Medical Center

Türkiye, Eskisehir

Turkish Society of Internal Medicine

From 2019-2020 to 2023-2024

Turkish Society of Internal Medicine (TSIM) was founded in 1995 as a non-profit organization and since then the Society has grown fast and reached over 1300 members currently.

The Society has a mission to be leader in the training and continuing medical education of internal medicine specialists and subspecialists; and in the delivery of high-quality patient care.

Aligned with this mission, one of the goals of the Society is to support scientific research projects in the field of internal medicine and to mediate a respectful relationship between the Society and the public, the academia and the industry.

Website
http://www.tihud.org.tr/ (in turkish)

Contact
• Dr Serhat UNAL, Main Investigator
• Dr Mine DURUSU TANRIOVER, Co-Investigator and Site Coordinator

Hospitals
• Ministry of Health, Ankara Research and Training Hospital
• Ankara University Faculty of Medicine, Children’s Hospital
• Hacettepe University Faculty of Medicine, Adult Hospital
• Ankara Bilkent City Hospital